BR9812325A - Novo uso para budesonida e formoterol - Google Patents

Novo uso para budesonida e formoterol

Info

Publication number
BR9812325A
BR9812325A BR9812325-4A BR9812325A BR9812325A BR 9812325 A BR9812325 A BR 9812325A BR 9812325 A BR9812325 A BR 9812325A BR 9812325 A BR9812325 A BR 9812325A
Authority
BR
Brazil
Prior art keywords
budesonide
formoterol
new use
new
formotherol
Prior art date
Application number
BR9812325-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9812325(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR9812325A publication Critical patent/BR9812325A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9812325-4A 1997-09-19 1998-09-09 Novo uso para budesonida e formoterol BR9812325A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use
PCT/SE1998/001599 WO1999015182A1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol

Publications (1)

Publication Number Publication Date
BR9812325A true BR9812325A (pt) 2000-09-05

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812325-4A BR9812325A (pt) 1997-09-19 1998-09-09 Novo uso para budesonida e formoterol

Country Status (38)

Country Link
US (2) US7897646B2 (US07122603-20061017-C00045.png)
EP (2) EP1210943B1 (US07122603-20061017-C00045.png)
JP (1) JP2001517630A (US07122603-20061017-C00045.png)
KR (1) KR20010024140A (US07122603-20061017-C00045.png)
CN (1) CN1149998C (US07122603-20061017-C00045.png)
AR (1) AR013506A1 (US07122603-20061017-C00045.png)
AT (2) ATE329599T1 (US07122603-20061017-C00045.png)
AU (1) AU757235B2 (US07122603-20061017-C00045.png)
BR (1) BR9812325A (US07122603-20061017-C00045.png)
CA (1) CA2302700C (US07122603-20061017-C00045.png)
CY (1) CY1106156T1 (US07122603-20061017-C00045.png)
CZ (1) CZ295250B6 (US07122603-20061017-C00045.png)
DE (2) DE69834955T2 (US07122603-20061017-C00045.png)
DK (2) DK1014993T3 (US07122603-20061017-C00045.png)
EE (1) EE04297B1 (US07122603-20061017-C00045.png)
ES (2) ES2182357T3 (US07122603-20061017-C00045.png)
HK (1) HK1045812B (US07122603-20061017-C00045.png)
HU (1) HUP0003848A2 (US07122603-20061017-C00045.png)
ID (1) ID24838A (US07122603-20061017-C00045.png)
IL (1) IL134773A (US07122603-20061017-C00045.png)
IN (1) IN190791B (US07122603-20061017-C00045.png)
IS (1) IS2715B (US07122603-20061017-C00045.png)
MX (1) MXPA00002615A (US07122603-20061017-C00045.png)
MY (1) MY127812A (US07122603-20061017-C00045.png)
NO (1) NO327176B1 (US07122603-20061017-C00045.png)
NZ (1) NZ503173A (US07122603-20061017-C00045.png)
PL (1) PL190782B1 (US07122603-20061017-C00045.png)
PT (2) PT1210943E (US07122603-20061017-C00045.png)
RU (1) RU2199322C2 (US07122603-20061017-C00045.png)
SA (1) SA98190773B1 (US07122603-20061017-C00045.png)
SE (1) SE9703407D0 (US07122603-20061017-C00045.png)
SI (2) SI1014993T1 (US07122603-20061017-C00045.png)
SK (1) SK285330B6 (US07122603-20061017-C00045.png)
TR (1) TR200000726T2 (US07122603-20061017-C00045.png)
TW (1) TW546140B (US07122603-20061017-C00045.png)
UA (1) UA72446C2 (US07122603-20061017-C00045.png)
WO (1) WO1999015182A1 (US07122603-20061017-C00045.png)
ZA (1) ZA988516B (US07122603-20061017-C00045.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
PT1131059E (pt) * 1998-11-13 2003-07-31 Jago Res Ag Po seco para inalacao
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
ATE369121T1 (de) * 2001-02-06 2007-08-15 Innovata Biomed Ltd Bimodale trockenpulverzusammensetzung zur inhalation
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
KR20050056222A (ko) * 2002-09-30 2005-06-14 아쿠스피어 인코포레이티드 흡입용 지속 방출형 다공성 미세입자
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
BRPI0613034A8 (pt) 2005-07-14 2018-01-02 Lipothera Inc formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo.
US20070148211A1 (en) * 2005-12-15 2007-06-28 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
US20100119609A1 (en) * 2006-10-17 2010-05-13 John Daniel Dobak Methods, compositions, and formulations for the treatment of thyroid eye disease
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
HUE047834T2 (hu) 2009-05-29 2020-05-28 Pearl Therapeutics Inc Nyújtott hatású muszkarin antagonisták és nyújtott hatású béta 2 adrenerg receptor agonisták pulmonáris beadására alkalmas készítmények és ezekkel kapcsolatos eljárások és rendszerek
CA2764867C (en) * 2009-06-09 2016-05-17 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
EA028679B1 (ru) * 2010-01-15 2017-12-29 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Составы в виде лиофилизированного кека
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
WO2012129237A2 (en) 2011-03-20 2012-09-27 Trustees Of Boston University Therapeutic agent for emphysema and copd
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
KR102275109B1 (ko) 2013-03-15 2021-07-07 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
CN112472689B (zh) 2015-12-04 2023-01-17 墨西哥氟石股份公司 药物组合物
AU2019287541A1 (en) 2018-06-14 2021-01-21 Astrazeneca Uk Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416950B1 (en) 1989-09-08 1993-08-11 Glaxo Group Limited Medicaments
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
EP0613371B1 (en) 1991-12-18 2002-03-06 AstraZeneca AB New combination of formoterol and budesonide
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
EA002124B1 (ru) * 1995-11-24 2001-12-24 Смитклайн Бичам С.П.А. Производные хинолина
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1009408A1 (en) 1997-06-27 2000-06-21 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
UA72446C2 (uk) 2005-03-15
AU757235B2 (en) 2003-02-06
IL134773A (en) 2005-03-20
DE69834955T2 (de) 2007-01-25
IL134773A0 (en) 2001-04-30
MY127812A (en) 2006-12-29
EP1210943A1 (en) 2002-06-05
US20110097282A1 (en) 2011-04-28
DE69807239T2 (de) 2003-04-10
NO20001401D0 (no) 2000-03-17
JP2001517630A (ja) 2001-10-09
US7897646B2 (en) 2011-03-01
SI1014993T1 (en) 2003-02-28
CZ2000950A3 (cs) 2000-06-14
NO327176B1 (no) 2009-05-04
CN1149998C (zh) 2004-05-19
US20020042404A1 (en) 2002-04-11
EP1014993B1 (en) 2002-08-14
NZ503173A (en) 2001-08-31
DK1210943T3 (da) 2006-09-18
AU9192898A (en) 1999-04-12
SE9703407D0 (sv) 1997-09-19
CA2302700A1 (en) 1999-04-01
DE69807239D1 (de) 2002-09-19
US20060189587A9 (en) 2006-08-24
CY1106156T1 (el) 2011-06-08
TR200000726T2 (tr) 2000-09-21
DK1014993T3 (da) 2002-11-11
PT1014993E (pt) 2002-12-31
HUP0003848A2 (hu) 2001-08-28
PL339295A1 (en) 2000-12-04
MXPA00002615A (es) 2002-04-24
AR013506A1 (es) 2000-12-27
EE200000145A (et) 2001-02-15
PT1210943E (pt) 2006-09-29
CN1271287A (zh) 2000-10-25
WO1999015182A1 (en) 1999-04-01
CA2302700C (en) 2010-11-23
SK3892000A3 (en) 2000-12-11
IN190791B (US07122603-20061017-C00045.png) 2003-08-23
ZA988516B (en) 1999-03-19
SA98190773B1 (ar) 2006-10-02
HK1045812B (zh) 2006-12-22
EP1014993A1 (en) 2000-07-05
PL190782B1 (pl) 2006-01-31
IS2715B (is) 2011-02-15
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
IS5407A (is) 2000-03-15
NO20001401L (no) 2000-03-17
TW546140B (en) 2003-08-11
ID24838A (id) 2000-08-24
CZ295250B6 (cs) 2005-06-15
ES2182357T3 (es) 2003-03-01
DE69834955D1 (de) 2006-07-27
ATE329599T1 (de) 2006-07-15
EP1210943B1 (en) 2006-06-14
EE04297B1 (et) 2004-06-15
SI1210943T1 (sl) 2006-10-31
SK285330B6 (sk) 2006-11-03
HK1045812A1 (en) 2002-12-13
ES2266322T3 (es) 2007-03-01
US8461211B2 (en) 2013-06-11
ATE222106T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
BR9812325A (pt) Novo uso para budesonida e formoterol
ID27606A (id) Penghantaran raloksifen secara pulmonary dan nasal
CY2010018I2 (el) Ενωσεις τυπου αμινοκυκλοεξυλο αιθερια και η χρηση των
DE69838984D1 (de) Risikoabschätzung für chronische atemwegserkrankungen und anwendungen
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
NO308767B1 (no) Dilator for ytre veggvev av menneskelig anatomi
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
ATE390133T1 (de) Gabapentinanaloga für schlafstörungen
IT1313205B1 (it) Giunto con migliorata stabilita' di frenatura e minore deformazioneper eccessivo serraggio.
DE69819193D1 (de) Dehnungsmessstreifen und dessen anwendungen
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
MA25834A1 (fr) Utilisation d'une combinaison de salmeterol et de propionate de fluticasone.
BR9713514A (pt) Novo uso de creatina
DE69830259D1 (de) Gewebeschutzmittel und der Gebrauch desselben
Font et al. Finding the words: Instruments for a therapy of liberation
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica
DE69803634D1 (de) Herstellung von Phenol und dessen Derivaten
IT1276213B1 (it) Composizioni dermatologiche e cosmetiche atte all'applicazione topica, ad effetto modulante sulle ceramidi endogene dell'epidermide
FR2715821B1 (fr) Dispositif d'aide à la rééducation fonctionnelle, notamment du rachis.
IT1280863B1 (it) Procedimento per produrre una forma attiva di incenso e relativo uso dell'incenso stesso.
ATE179714T1 (de) Gegen papillomaviren wirksame 2',5'-oligoadenylat-2',3'-cyclophosphate und 2',5'-oligoadenylate
FR2719484B1 (fr) Ventilateur à usage médical.
SE9803737D0 (sv) a new system and its units and the use of thereof
ITPE20000006A0 (it) Pannolino ad alta vestibilita' e relativo apparato produttivo

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B12B Appeal against refusal [chapter 12.2 patent gazette]